What Payers Will Demand From Evidence in 2026

The start of a new year brings more than refreshed planning cycles, it brings a reset in payer expectations. As 2026 gets underway, payers are signaling that the evidence bar is rising. Traditional endpoints alone are no longer sufficient. Retrospective analyses...

AI & Predictive Modeling Are Transforming HEOR

For years, HEOR teams have focused on describing the past: analyzing retrospective claims, EMR data, and trial endpoints to understand treatment patterns and cost trajectories. But the next competitive edge in market access won’t come from explaining what happened. It...

CMS Transparency Rules: What Manufacturers Must Prepare For

The market access landscape is shifting. This time, the catalyst isn’t just pricing reform. It’s transparency. The Centers for Medicare & Medicaid Services (CMS) is expanding disclosure requirements around pricing, contracting, and value justification. What used...